Health stocks hit after Trump taps RFK Jr for top job
The news prompted a sell-off across the industry. In the US, shares in Pfizer and Moderna sank more than 5% in early trading, while UK-listed firms AstraZeneca and GSK dropped 2% or more. Russ Mould, investment director at AJ Bell, said the pick had “spooked” shareholders, despite questions about how the new administration might pursue its threats.